The Pharmacy Times® Cardiovascular Health resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
What can we help you find?
Understanding risk factors and treatments for irregular heart rhythms may be especially important during the COVID-19 pandemic.
Conduct proper review and evaluation of ARV and DOAC pharmacokinetics and metabolism prior to recommending treatment.
Pharmacy Times® spoke with Jenine Abuzir, PharmD candidate at Chicago College of Pharmacy at Midwestern University, about her experience teaching in the Women’s Health elective during pharmacy school.
What would you recommend to these patients?
Researchers found the largest decreases for heart attack risk among women, which may be because of greater attention paid to women’s heart health in recent decades.
A new study found that hypertension is a common comorbidity in patients with COVID-19.
Top news of the week from Pharmacy Times®.
Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.
Mindfulness training may hold the key to reducing the risk of cardiovascular disease, which is rapidly becoming the leading cause of death worldwide.
Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.
Mailing educational materials to patients with atrial fibrillation and their clinicians did not increase the use of stroke prevention drugs.
Patients reported their likeness of having support from a trusted health care professional, rapid feedback, and adjustments to their treatment with someone to be accountable to, according to the study authors.